NASHVILLE — In this video, Elliot Tapper, MD, FAASLD, discusses a presentation from the ACG Annual Meeting about when it is safe to stop cancer therapy when it results in hepatitis.“While it might feel inelegant to simultaneously turbocharge someone’s immune…
New Delhi, Oct 30 (PTI) Sun Pharmaceutical Industries Ltd on Friday said the US health regulator has approved its supplemental Biologics License Application (sBLA) for ILUMYA (tildrakizumab-asmn) for treatment of adults with active psoriatic arthritis (PsA). The US Food and Drug…
Artificial intelligence (AI)-assisted radiographic tools offer new opportunities for diagnostic training in dental education, but evidence regarding their effect on independent student performance remains limited. This prospective randomized pilot study evaluated whether four weeks of supplementary training with an…
‘Fox News @ Night’ talks to patients, doctors and other stakeholders about the FDA-approved immunotherapy’s success. New immunotherapy shown to halt melanoma in study ‘Fox News @ Night’ talks to patients, doctors and other stakeholders about the FDA-approved immunotherapy’s success.
"This circuit acts like a rheostat that continuously fine tunes the stem cells' response to the environment at the skin surface," says first author Anita Gola, a research associate in the Robin Chemers Neustein Laboratory of Mammalian Cell Biology and…
The most striking discovery came from the tumor cells themselves. Elevated gene expression of SLC7A5 and SOX2 was associated with poor response and early progression. The work also highlights the complexity of immunotherapy resistance in this cancer type. The full open-access article,…
Psoriatic arthritis is a chronic inflammatory immune-mediated disease associated with significant impairment and reduced quality of life. Although a clinical protocol for its treatment exists within the SUS, the coverage and socioeconomic distribution of pharmacological treatment across Brazil’s states and…
A real-world US survey of 267 adolescents and adults with moderate-to-severe atopic dermatitis found that 68% disliked how their topical therapy made their skin feel, while agreement between patients and healthcare providers on treatment satisfaction was only moderate and dropped to fair…
Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors. Regimens should also match hair type. Sebum has a harder time traveling down a curly hair shaft, so these patients…
Mark Lebwohl, MD, recently discussed the atopic march and systemic options for pediatric atopic dermatitis. He highlighted a recent poster by Eric Simpson, MD, and colleagues comparing dupilumab with systemic corticosteroids. Lebwohl also reviewed approved biologics and JAK inhibitors, along…
Skin cancer checks, eczema/psoriasis, acne care, and cosmetic dermatology news.
An article joins this feed when it matches these terms. Each one is also a search of its own.